New Drug Approvals

Home » Posts tagged 'Dr Reddy’s Laboratories'

Tag Archives: Dr Reddy’s Laboratories


Blog Stats

  • 4,303,243 hits

Flag and hits

Flag Counter

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,821 other subscribers
Follow New Drug Approvals on



Recent Posts

Flag Counter


Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL 

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,821 other subscribers


DR ANTHONY MELVIN CRASTO, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his Ph.D from ICT, 1991,Matunga, Mumbai, India, in Organic Chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with AFRICURE PHARMA, ROW2TECH, NIPER-G, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India as ADVISOR, earlier assignment was with GLENMARK LIFE SCIENCES LTD, as CONSUlTANT, Retired from GLENMARK in Jan2022 Research Centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Total Industry exp 32 plus yrs, Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri, etc, He did custom synthesis for major multinationals in his career like BASF, Novartis, Sanofi, etc., He has worked in Discovery, Natural products, Bulk drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, etc, he is now helping millions, has 9 million plus hits on Google on all Organic chemistry websites. His friends call him Open superstar worlddrugtracker. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 32 PLUS year tenure till date Feb 2023, Around 35 plus products in his career. He has good knowledge of IPM, GMP, Regulatory aspects, he has several International patents published worldwide . He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc., He suffered a paralytic stroke/ Acute Transverse mylitis in Dec 2007 and is 90 %Paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, He has 100 million plus hits on Google, 2.5 lakh plus connections on all networking sites, 100 Lakh plus views on dozen plus blogs, 227 countries, 7 continents, He makes himself available to all, contact him on +91 9323115463, email, Twitter, @amcrasto , He lives and will die for his family, 90% paralysis cannot kill his soul., Notably he has 38 lakh plus views on New Drug Approvals Blog in 227 countries...... , He appreciates the help he gets from one and all, Friends, Family, Glenmark, Readers, Wellwishers, Doctors, Drug authorities, His Contacts, Physiotherapist, etc He has total of 32 International and Indian awards

Personal Links

Verified Services

View Full Profile →



Flag Counter

Dr. Reddy’s Laboratories CEO G V Prasad has been recognized as one of India’s top 5 most valuable CEOs

reddyDr. Reddy's Laboratories

CEO G V Prasad has been recognized as one of India’s top 5 most valuable CEOs Read more:


////////Dr. Reddy’s Laboratories,  CEO , G V Prasad, India’s top 5 most valuable CEOs

SCRIP Awards 2013 -Best Company in an Emerging Market – Dr Reddy’s Laboratories – India, Novartis’s Bexsero, Best New Drug


The SCRIP Awards 2013 celebrated achievements in the global biopharma industry last night at the Lancaster, London.

Hosted by Justin Webb, the evening was a fantastic mix of dining, entertainment and awards.

Among the winners were:

  • Novartis’s Bexsero, Best New Drug
  • Genmab, Biotech Company of the Year
  • Regeneron Pharmaceuticals and Sanofi’s Phase IIa study dupilumab in asthma, Clinical Advance of the Year

You can view the full roll of honour by clicking on the button below.

It was a great night and we would like to thank all those who entered and attended this year’s awards.

Finally congratulations to our winners and a huge thanks to our sponsors for helping us make it such a fantastic success.

Don’t forget to check our website in the next couple of days for all the pictures from the night.

2013 Winners

Best Company in an Emerging Market – Sponsored by Clinigen Group

  • Dr Reddy’s Laboratories – India

Best Technological Development in Clinical Trials

  • Quintiles’s Infosario Safety

Best Partnership Alliance

  • AstraZeneca with Bristol-Myers Squibb and Amylin in diabetes

Financing Deal of the Year

  • Mesoblast’s equity financing of Aus$170m

Best Advance in an Emerging Market

  • Novartis’s Jian Kang Kuai Che Healthcare Project in China

Clinical Advance of the Year – Sponsored by Quintiles

  • Regeneron Pharmaceuticals and Sanofi’s Phase IIa study dupilumab in in asthma

Licensing Deal of the Year – Sponsored by Hume Brophy

  • AstraZeneca and Horizon Discovery for the development and commercialization of the HD-001 kinase target program for multiple cancer types

Executive of the Year

  • Roch Doliveux, chairman and chief executive officer of UCB

Biotech Company of the Year

  • Genmab

Best Contract Research Organization

  • Quintiles

Management Team of the Year

  • Regeneron Pharmaceuticals’ CEO Leonard S Schleifer and CSO George D Yancopoulos

Best New Drug – Sponsored by INC Research

  • Novartis’ Bexsero (meningococcal group B vaccine)

Pharma Company of the Year – Sponsored by ICON

  • Astellas

Lifetime Achievement Award

  • Prof Dr Désiré Collen




…….read about bexero at



MOBILE-+91 9323115463
%d bloggers like this: